Gordon Dunn
Director of Finance/CFO bij QUOIN PHARMACEUTICALS, LTD.
Vermogen: - $ op 29-02-2024
Profiel
Gordon B.
Dunn occupies the position of Chief Financial Officer for Quoin Pharmaceuticals Ltd.
Mr. Dunn is also on the board of Health Technologies Ltd.
In his past career he was Chief Financial Officer of Golden Bough Ltd., Co-Head-European Private Equity Group at Merrill Lynch Ltd., Chief Financial Officer at Innocoll, Inc., Finance Director-Europe & Vice President at Innocoll AG and Private Equity Portfolio Manager at NS Asset Management LLP.
Mr. Dunn received an undergraduate degree from Stanford University and a graduate degree from New York University School of Law.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
26-10-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Gordon Dunn
Bedrijven | Functie | Begin |
---|---|---|
QUOIN PHARMACEUTICALS, LTD. | Director of Finance/CFO | 01-11-2021 |
Health Technologies Ltd.
Health Technologies Ltd. Pharmaceuticals: MajorHealth Technology Health Technologies Ltd., operating under the name Qured, offers personalized employee health checks and screening to improve team health, satisfaction, and productivity. The company is based in London, UK. The British company's at-home blood tests are designed to help individuals live longer, healthier lives by testing for important health indicators such as organ function, fertility profile, and cancer warning signs. Qured's mission is to provide personalized healthcare for everyone, aided by digital technologies. | Director/Board Member | 20-05-2019 |
Eerdere bekende functies van Gordon Dunn
Bedrijven | Functie | Einde |
---|---|---|
Golden Bough Ltd. | Director of Finance/CFO | 01-01-2021 |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Director of Finance/CFO | 31-08-2015 |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Director of Finance/CFO | 01-01-2016 |
NS Asset Management LLP
NS Asset Management LLP Investment ManagersFinance N S Asset Management LLP (NAM) is the asset management subsidiary of NS Holdings LLP ultimately held by Man Group Plc (LSE: EMG, ADR: MNGPY) in Great Britain. Established in 2003, the firm provides investment management services across a range of investment strategies to corporations, governments, pension plans, insurance companies, endowments foundations and high net-worth individuals. NAM is based in London and has additional offices in Singapore, Hong Kong, Tokyo and New York. | Portfolio Manager-Equities | 01-08-2014 |
Merrill Lynch Ltd. | Corporate Officer/Principal | - |
Opleiding van Gordon Dunn
Stanford University | Undergraduate Degree |
New York University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
QUOIN PHARMACEUTICALS, LTD. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
NS Asset Management LLP
NS Asset Management LLP Investment ManagersFinance N S Asset Management LLP (NAM) is the asset management subsidiary of NS Holdings LLP ultimately held by Man Group Plc (LSE: EMG, ADR: MNGPY) in Great Britain. Established in 2003, the firm provides investment management services across a range of investment strategies to corporations, governments, pension plans, insurance companies, endowments foundations and high net-worth individuals. NAM is based in London and has additional offices in Singapore, Hong Kong, Tokyo and New York. | Finance |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Health Technology |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Merrill Lynch Ltd. | Miscellaneous |
Golden Bough Ltd. | Technology Services |
Health Technologies Ltd.
Health Technologies Ltd. Pharmaceuticals: MajorHealth Technology Health Technologies Ltd., operating under the name Qured, offers personalized employee health checks and screening to improve team health, satisfaction, and productivity. The company is based in London, UK. The British company's at-home blood tests are designed to help individuals live longer, healthier lives by testing for important health indicators such as organ function, fertility profile, and cancer warning signs. Qured's mission is to provide personalized healthcare for everyone, aided by digital technologies. | Health Technology |